US Stock MarketDetailed Quotes

MGRX Mangoceuticals

Watchlist

2.370
+0.110+4.87%

Close Nov 4 16:00 ET

2.320
-0.050-2.11%

Post 18:03 ET

5.04MMarket Cap-504P/E (TTM)

Mangoceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.42%-1.58M

45.19%-991.13K

-419.66%-7M

-161.37%-1.7M

-184.96%-1.71M

-2,185.38%-1.78M

-9,570.06%-1.81M

-1.35M

-3,607.53%-649.56K

-600.35K

Net income from continuing operations

-4.70%-2.39M

7.55%-2.37M

-361.07%-9.21M

-281.21%-2.57M

-84.50%-1.8M

-593.21%-2.28M

-12,966.41%-2.56M

---2M

-3,705.75%-673.66K

---975.32K

Operating gains losses

----

---151.82K

----

Depreciation and amortization

-48.51%3.21K

2.33%6.22K

544.29%24.89K

62.85%6.29K

--6.29K

--6.22K

--6.08K

--3.86K

--0

Other non cash items

113.43%808.4K

-40.65%416.5K

178.88%1.52M

591.99%358.9K

-68.28%84.75K

67.16%378.77K

78,838.13%701.76K

--546.54K

28,554.70%51.87K

--267.2K

Change In working capital

-634.46%-289.57K

4,789.18%915.8K

120.00%41.51K

35.98%76.04K

-11.48%-69.17K

116.72%54.18K

---19.53K

--18.87K

--55.92K

---62.05K

-Change in receivables

----

131.55%54.98K

----

---174.24K

----

-Change in inventory

101.84%433

--4.05K

---18.5K

--3.08K

--1.91K

---23.49K

--0

-Change in prepaid assets

317.60%46.75K

104.62%902

-71.53%-49.21K

159.40%23.43K

16.16%-31.62K

---21.49K

---19.53K

---28.69K

--9.03K

---37.72K

-Change in payables and accrued expense

-436.02%-335.81K

--911.79K

204.92%110.97K

40.26%50.1K

-60.59%-39.07K

299.75%99.94K

--0

--36.39K

--35.72K

---24.33K

-Change in other current assets

-45.42%14.78K

--14.47K

----

--13.73K

--27.08K

--0

----

--0

-Change in other current liabilities

43.57%-15.72K

---15.41K

-130.60%-56.73K

-107.95%-14.75K

---14.12K

---27.86K

--0

--185.41K

--0

Cash from discontinued investing activities

Operating cash flow

11.42%-1.58M

45.19%-991.13K

-419.66%-7M

-161.37%-1.7M

-184.96%-1.71M

-2,185.67%-1.78M

-9,564.90%-1.81M

---1.35M

-3,607.53%-649.56K

---600.35K

Investing cash flow

Cash flow from continuing investing activities

65K

91.84%-3.52K

-3.52K

-43.1K

-40.57K

-2.53K

Net PPE purchase and sale

--65K

--0

91.84%-3.52K

--0

---3.52K

---43.1K

---40.57K

---2.53K

Cash from discontinued investing activities

Investing cash flow

--65K

--0

91.84%-3.52K

--0

---3.52K

---43.1K

---40.57K

---2.53K

Financing cash flow

Cash flow from continuing financing activities

131.99%1.99M

-94.65%267.5K

244.26%7.06M

140.24%1.2M

3,337.79%857.04K

9,900.00%5M

2.05M

1,146.57%499.5K

1.48M

Net issuance payments of debt

159.72%100K

--87.5K

-435.39%-167.46K

--0

-771.72%-167.46K

--0

--49.93K

--0

---25K

Net common stock issuance

--388.27K

-96.40%180K

210.00%6.2M

140.24%1.2M

--0

--5M

--2M

62,337.50%499.5K

--1.5M

Proceeds from stock option exercised by employees

----

--1.02M

--0

----

--0

Cash from discontinued financing activities

Financing cash flow

131.99%1.99M

-94.65%267.5K

244.26%7.06M

140.24%1.2M

--0

3,337.79%857.04K

9,900.00%5M

--2.05M

1,146.57%499.5K

--1.48M

Net cash flow

Beginning cash position

-99.60%15.31K

8.22%739.01K

2,928.20%682.86K

41.59%1.24M

339,473.16%2.95M

7,089.89%3.87M

2,928.20%682.86K

--22.55K

--873.49K

--868

Current changes in cash

151.54%476.03K

-122.70%-723.63K

-91.50%56.15K

-161.10%-497.74K

-296.05%-1.71M

-1,643.46%-923.54K

10,089.13%3.19M

--660.31K

-945.37%-190.63K

--872.62K

Effect of exchange rate changes

---1.1K

---70

----

--0

----

End cash Position

-83.37%490.24K

-99.60%15.31K

8.22%739.01K

41.59%1.24M

339,473.16%2.95M

7,089.89%3.87M

--682.86K

2,928.20%682.86K

--873.49K

Free cash flow

11.42%-1.58M

45.30%-991.13K

-403.80%-7M

-146.00%-1.7M

-183.76%-1.71M

-2,185.67%-1.78M

-9,583.70%-1.81M

---1.39M

-3,839.10%-690.13K

---602.88K

Currency Unit

USD

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.42%-1.58M	45.19%-991.13K	-419.66%-7M	-161.37%-1.7M	-184.96%-1.71M	-2,185.38%-1.78M	-9,570.06%-1.81M	-1.35M	-3,607.53%-649.56K	-600.35K
Net income from continuing operations	-4.70%-2.39M	7.55%-2.37M	-361.07%-9.21M	-281.21%-2.57M	-84.50%-1.8M	-593.21%-2.28M	-12,966.41%-2.56M	---2M	-3,705.75%-673.66K	---975.32K
Operating gains losses	----	----	----	----	----	----	----	---151.82K	----	----
Depreciation and amortization	-48.51%3.21K	2.33%6.22K	544.29%24.89K	62.85%6.29K	--6.29K	--6.22K	--6.08K	--3.86K	--3.86K	--0
Other non cash items	113.43%808.4K	-40.65%416.5K	178.88%1.52M	591.99%358.9K	-68.28%84.75K	67.16%378.77K	78,838.13%701.76K	--546.54K	28,554.70%51.87K	--267.2K
Change In working capital	-634.46%-289.57K	4,789.18%915.8K	120.00%41.51K	35.98%76.04K	-11.48%-69.17K	116.72%54.18K	---19.53K	--18.87K	--55.92K	---62.05K
-Change in receivables	----	----	131.55%54.98K	----	----	----	----	---174.24K	----	----
-Change in inventory	101.84%433	--4.05K	---18.5K	--3.08K	--1.91K	---23.49K	--0	--0	--0	--0
-Change in prepaid assets	317.60%46.75K	104.62%902	-71.53%-49.21K	159.40%23.43K	16.16%-31.62K	---21.49K	---19.53K	---28.69K	--9.03K	---37.72K
-Change in payables and accrued expense	-436.02%-335.81K	--911.79K	204.92%110.97K	40.26%50.1K	-60.59%-39.07K	299.75%99.94K	--0	--36.39K	--35.72K	---24.33K
-Change in other current assets	-45.42%14.78K	--14.47K	----	----	--13.73K	--27.08K	--0	----	----	--0
-Change in other current liabilities	43.57%-15.72K	---15.41K	-130.60%-56.73K	-107.95%-14.75K	---14.12K	---27.86K	--0	--185.41K	--185.41K	--0
Cash from discontinued investing activities
Operating cash flow	11.42%-1.58M	45.19%-991.13K	-419.66%-7M	-161.37%-1.7M	-184.96%-1.71M	-2,185.67%-1.78M	-9,564.90%-1.81M	---1.35M	-3,607.53%-649.56K	---600.35K
Investing cash flow
Cash flow from continuing investing activities	65K	0	91.84%-3.52K	0	0	0	-3.52K	-43.1K	-40.57K	-2.53K
Net PPE purchase and sale	--65K	--0	91.84%-3.52K	--0	--0	--0	---3.52K	---43.1K	---40.57K	---2.53K
Cash from discontinued investing activities
Investing cash flow	--65K	--0	91.84%-3.52K	--0	--0	--0	---3.52K	---43.1K	---40.57K	---2.53K
Financing cash flow
Cash flow from continuing financing activities	131.99%1.99M	-94.65%267.5K	244.26%7.06M	140.24%1.2M	0	3,337.79%857.04K	9,900.00%5M	2.05M	1,146.57%499.5K	1.48M
Net issuance payments of debt	159.72%100K	--87.5K	-435.39%-167.46K	--0	--0	-771.72%-167.46K	--0	--49.93K	--0	---25K
Net common stock issuance	--388.27K	-96.40%180K	210.00%6.2M	140.24%1.2M	--0	--0	--5M	--2M	62,337.50%499.5K	--1.5M
Proceeds from stock option exercised by employees	----	----	--1.02M	--0	--0	----	----	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	131.99%1.99M	-94.65%267.5K	244.26%7.06M	140.24%1.2M	--0	3,337.79%857.04K	9,900.00%5M	--2.05M	1,146.57%499.5K	--1.48M
Net cash flow
Beginning cash position	-99.60%15.31K	8.22%739.01K	2,928.20%682.86K	41.59%1.24M	339,473.16%2.95M	7,089.89%3.87M	2,928.20%682.86K	--22.55K	--873.49K	--868
Current changes in cash	151.54%476.03K	-122.70%-723.63K	-91.50%56.15K	-161.10%-497.74K	-296.05%-1.71M	-1,643.46%-923.54K	10,089.13%3.19M	--660.31K	-945.37%-190.63K	--872.62K
Effect of exchange rate changes	---1.1K	---70	----	----	----	--0	--0	----	----	----
End cash Position	-83.37%490.24K	-99.60%15.31K	8.22%739.01K	8.22%739.01K	41.59%1.24M	339,473.16%2.95M	7,089.89%3.87M	--682.86K	2,928.20%682.86K	--873.49K
Free cash flow	11.42%-1.58M	45.30%-991.13K	-403.80%-7M	-146.00%-1.7M	-183.76%-1.71M	-2,185.67%-1.78M	-9,583.70%-1.81M	---1.39M	-3,839.10%-690.13K	---602.88K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data